Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

6-Hydroxydopamine therapy in glaucoma

H Watanabe, R Z Levene, M R Bernstein

    Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Correlation between labeling index by proliferating cell nuclear antigen (PCNA) staining and growth rate in nude mice: preliminary report].

    Nihon Geka Gakkai zasshi·1992
    Same author

    Immunohistochemical study of the histogenesis of esophageal carcinosarcoma.

    Japanese journal of clinical oncology·1992
    Same author

    Decreased aortic compliance aggravates subendocardial ischaemia in dogs with stenosed coronary artery.

    Cardiovascular research·1992
    Same author

    Immunohistochemical study of the sympathetic and sensory innervation to the blood vessels of the dog forepaw.

    The Tohoku journal of experimental medicine·1992
    Same author

    [Human lung cancer cell lines in our laboratory: establishment of three large cell carcinoma cell lines and their biological characterization].

    Human cell·1992
    Same author

    Ambulatory blood pressure and postprandial hypotension.

    American heart journal·1992
    Same journal

    Complications of polyglactin 910 sutures.

    Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology·1977
    Same journal

    A new academy--new responsibilities.

    Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology·1977
    Same journal

    President's message. American Academy of Ophthalmology and Otolaryngology.

    Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology·1977
    Same journal

    Directory of ophthalmic societies.

    Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology·1977
    Same journal

    Ethics in ophthalmology.

    Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology·1977
    Same journal

    New ultrasharp knife.

    Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology·1977
    See all related articles

    6-hydroxydopamine (6-HD) therapy showed effectiveness in 41% of glaucoma patients, with iontophoresis proving a practical delivery method. This treatment offers a potential new avenue for managing intraocular pressure.

    Area of Science:

    • Ophthalmology
    • Pharmacology

    Background:

    • Glaucoma is a leading cause of irreversible blindness.
    • Effective management of intraocular pressure (IOP) is crucial in glaucoma treatment.
    • Novel therapeutic approaches are needed to improve IOP control.

    Purpose of the Study:

    • To evaluate the efficacy and practicality of 6-hydroxydopamine (6-HD) for lowering intraocular pressure in glaucoma patients.
    • To compare the effectiveness of 6-HD administration via subconjunctival injection versus iontophoresis.

    Main Methods:

    • 6-hydroxydopamine (6-HD) was administered to 137 eyes of 100 glaucoma patients.
    • Delivery methods included subconjunctival injection and iontophoresis.
    • Patient data from those receiving maximum medical therapy or prior glaucoma surgery were analyzed.

    Related Experiment Videos

    Main Results:

    • 6-HD therapy was effective in 41% of analyzed patients (n=49).
    • Median peak IOP reduction was 13 mm Hg (subconjunctival) and 6 mm Hg (iontophoresis).
    • The median effective duration of IOP lowering was 2.5 months; iontophoresis was more practical.

    Conclusions:

    • 6-hydroxydopamine (6-HD) demonstrates potential as an adjunctive therapy for glaucoma.
    • Iontophoresis represents a more practical and efficient method for 6-HD administration.
    • Further research into 6-HD's role in glaucoma management is warranted.